Annual Total Long Term Liabilities
$85.43 M
+$12.57 M+17.26%
December 31, 2023
Summary
- As of February 7, 2025, IOVA annual total long term liabilities is $85.43 million, with the most recent change of +$12.57 million (+17.26%) on December 31, 2023.
- During the last 3 years, IOVA annual total long term liabilities has risen by +$28.34 million (+49.65%).
- IOVA annual total long term liabilities is now at all-time high.
Performance
IOVA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$99.60 M
-$2.54 M-2.49%
September 30, 2024
Summary
- As of February 7, 2025, IOVA quarterly total long term liabilities is $99.60 million, with the most recent change of -$2.54 million (-2.49%) on September 30, 2024.
- Over the past year, IOVA quarterly long term liabilities has dropped by -$6.99 million (-6.56%).
- IOVA quarterly long term liabilities is now -6.56% below its all-time high of $106.59 million, reached on March 31, 2024.
Performance
IOVA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
IOVA Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.3% | -6.6% |
| 3 y3 years | +49.6% | +34.6% |
| 5 y5 years | +10000.0% | +34.6% |
IOVA Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +28.5% | -6.6% | +49.8% |
| 5 y | 5-year | at high | +1194.4% | -6.6% | +2188.2% |
| alltime | all time | at high | -100.0% | -6.6% | -100.0% |
Iovance Biotherapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $99.60 M(-2.5%) |
| Jun 2024 | - | $102.14 M(-4.2%) |
| Mar 2024 | - | $106.59 M(+24.8%) |
| Dec 2023 | $85.43 M(+17.3%) | $85.43 M(-2.2%) |
| Sep 2023 | - | $87.35 M(-3.0%) |
| Jun 2023 | - | $90.08 M(+27.6%) |
| Mar 2023 | - | $70.61 M(-3.1%) |
| Dec 2022 | $72.86 M(+9.6%) | $72.86 M(-0.1%) |
| Sep 2022 | - | $72.94 M(-1.4%) |
| Jun 2022 | - | $74.00 M(+2.5%) |
| Mar 2022 | - | $72.18 M(+8.6%) |
| Dec 2021 | $66.47 M(+16.4%) | $66.47 M(+1.1%) |
| Sep 2021 | - | $65.73 M(+37.4%) |
| Jun 2021 | - | $47.84 M(-0.5%) |
| Mar 2021 | - | $48.08 M(-15.8%) |
| Dec 2020 | $57.09 M(+765.0%) | $57.09 M(+841.6%) |
| Sep 2020 | - | $6.06 M(+39.3%) |
| Jun 2020 | - | $4.35 M(-20.0%) |
| Mar 2020 | - | $5.44 M(-17.6%) |
| Dec 2019 | $6.60 M(+2769.6%) | $6.60 M(+8.7%) |
| Sep 2019 | - | $6.07 M(+30.1%) |
| Jun 2019 | - | $4.67 M(+5.3%) |
| Mar 2019 | - | $4.43 M(+1827.4%) |
| Dec 2018 | $230.00 K(-22.6%) | $230.00 K(>+9900.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(-100.0%) |
| Dec 2017 | $297.00 K(>+9900.0%) | $297.00 K(>+9900.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00 | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(-100.0%) |
| Mar 2014 | - | $167.10 K(>+9900.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00 | $0.00(0.0%) |
| Sep 2008 | - | $0.00(0.0%) |
| Jun 2008 | - | $0.00(0.0%) |
| Mar 2008 | - | $0.00 |
FAQ
- What is Iovance Biotherapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics annual total long term liabilities year-on-year change?
- What is Iovance Biotherapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly long term liabilities year-on-year change?
What is Iovance Biotherapeutics annual total long term liabilities?
The current annual total long term liabilities of IOVA is $85.43 M
What is the all time high annual total long term liabilities for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high annual total long term liabilities is $85.43 M
What is Iovance Biotherapeutics annual total long term liabilities year-on-year change?
Over the past year, IOVA annual total long term liabilities has changed by +$12.57 M (+17.26%)
What is Iovance Biotherapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of IOVA is $99.60 M
What is the all time high quarterly long term liabilities for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high quarterly total long term liabilities is $106.59 M
What is Iovance Biotherapeutics quarterly long term liabilities year-on-year change?
Over the past year, IOVA quarterly total long term liabilities has changed by -$6.99 M (-6.56%)